SCHEMBL12014104

SCHEMBL12014104

CC(C)c1cc(CN)cc(CN)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.37
LOXL2 Q9Y4K0 2/20 0.36
PLG P00747 2/20 0.36
KLK1 P06870 2/20 0.36
KLK6 Q92876 2/20 0.36
LMNA P02545 1/20 0.34
CSNK2A1 P68400 2/20 0.34
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
ALDH1A1 P00352 3/20 0.32
FABP3 P05413 2/20 0.32
FABP4 P15090 2/20 0.32
GAA P10253 1/20 0.32
ALOX12 P18054 1/20 0.32
HTT P42858 1/20 0.32
HIF1A Q16665 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
NOS3 P29474 2/20 0.31
NOS1 P29475 2/20 0.31
NOS2 P35228 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15249714 0.91 PLG (0.33) IDO1LOXL2PLGKLK1KLK6
SCHEMBL24140016 0.84 LOXL2 (0.38) IDO1LOXL2PLGKLK1KLK6
SCHEMBL13073607 0.84 PLG (0.32) IDO1LOXL2PLGKLK1KLK6
SCHEMBL3510813 0.82 FABP3 (0.34) LOXL2PLGKLK1KLK6FABP3
SCHEMBL3510133 0.81 ALDH1A1 (0.31) PLGKLK1KLK6ALDH1A1CYP3A4
SCHEMBL22092748 0.80 PDE2A (0.33) PLGKLK1KLK6
SCHEMBL3510032 0.78 KMT2A (0.38) PLGKLK1KLK6ALDH1A1FABP3
SCHEMBL18459293 0.78 ALDH1A1 (0.41) CSNK2A1ALDH1A1GAATAAR1
SCHEMBL3509053 0.78 LOX (0.35) LOXL2PLGKLK1KLK6FABP3
SCHEMBL14157384 0.78 IDO1 (0.32) IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-02-21 US disclosed
US-20220400728-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF CADENA BIO INC (US) 2022-12-22 US disclosed
US-20210352945-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF HERCULES CAPITAL, INC. 2021-11-18 US disclosed
US-20210002387-A1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF HERCULES CAPITAL, INC. 2021-01-07 US disclosed
EP-3096751-B1 12-EPI-PLEUROMUTILINS Nabriva Therapeutics GmbH (AT) 2021-01-06 EP disclosed
US-10849337-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof CADENA BIO, INC. (US) 2020-12-01 US disclosed
US-10752705-B2 Oligosaccharide compositions and methods for producing thereof CADENA BIO, INC. (US) 2020-08-25 US disclosed
EP-3250048-B1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF CADENA BIO INC (US) 2019-08-14 EP disclosed
US-9701628-B2 12-epi pleuromutilins NABRIVA THERAPEUTICS AG (AT) 2017-07-11 US disclosed
US-9701628-B2 12-epi pleuromutilins NABRIVA THERAPEUTICS AG (AT) 2017-07-11 US disclosed
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS Midori Renewables, Inc. (US) 2015-07-23 US disclosed
US-9079171-B2 Polymeric acid catalysts and uses thereof MIDORI USA, INC. (US) 2015-07-14 US disclosed
US-20140060522-A1 METHODS OF PRODUCING SUGARS FROM BIOMASS FEEDSTOCKS HERCULES CAPITAL, INC. 2014-03-06 US disclosed
US-8476388-B2 Polymeric acid catalysts and uses thereof Midori Renewables, Inc. (US) 2013-07-02 US disclosed
US-8466242-B2 Polymeric acid catalysts and uses thereof Midori Renewables, Inc. (US) 2013-06-18 US disclosed
US-20130042859-A1 POLYMERIC ACID CATALYSTS AND USES THEREOF Midori Renewables, Inc. (US) 2013-02-21 US disclosed
US-20130042859-A1 POLYMERIC ACID CATALYSTS AND USES THEREOF Midori Renewables, Inc. (US) 2013-02-21 US disclosed
US-20120252957-A1 POLYMERIC ACID CATALYSTS AND USES THEREOF Midori Renewables, Inc. (US) 2012-10-04 US disclosed
US-20120220740-A1 POLYMERIC ACID CATALYSTS AND USES THEREOF Midori Renewables, Inc. (US) 2012-08-30 US disclosed
US-20120220740-A1 POLYMERIC ACID CATALYSTS AND USES THEREOF Midori Renewables, Inc. (US) 2012-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210002387-A1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF OSTC, FUT5, FUT6 IDO1 1966/4885LOXL2 1080/4885PLG 1540/4885
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof OSTC, FUT5, FUT6 IDO1 1966/4885LOXL2 1080/4885PLG 1540/4885
US-10752705-B2 Oligosaccharide compositions and methods for producing thereof OSTC, FUT5, FUT6 IDO1 1966/4885LOXL2 1080/4885PLG 1540/4885
US-10849337-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof FUT5, FUT6, OSTC IDO1 2703/4885LOXL2 622/4885PLG 1886/4885
US-20210352945-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF OSTC, FUT5, FUT6 IDO1 2455/4885LOXL2 1415/4885PLG 2465/4885
US-20120252957-A1 POLYMERIC ACID CATALYSTS AND USES THEREOF MGAM, PGLS, GAA IDO1 1538/4885LOXL2 1332/4885PLG 308/4885
US-20120220740-A1 POLYMERIC ACID CATALYSTS AND USES THEREOF MGAM, PGLS, GAA IDO1 1666/4885LOXL2 1541/4885PLG 320/4885
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS MGAM, CEL, SI IDO1 1270/4885LOXL2 1352/4885PLG 486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.